Key takeaways from Marty Makary’s FDA confirmation hearing
Marty Makary, a career surgeon and President Trump’s nominee to run the Food and Drug Administration (FDA), faced senators in ...
BioSpace3d
Anxious Industry Awaits Makary’s Hearing Amid Disruptions, Layoffs at FDA
The Senate hearing for FDA Commissioner nominee Marty Makary comes after President Trump's NIH pick, Jay Bhattacharya, was ...
STAT5d
Wojcicki’s controversial bid to reclaim 23andMe
23andMe CEO Anne Wojcicki is attempting to buy her company back for a mere $42 million. It’s a fraction of the company’s ...
At the NIH, Intolerance Will No Longer Be Tolerated
Jay Bhattacharya has spent years railing against the National Institutes of Health. What happens when he runs it?
5 takeaways as Trump’s contrarian NIH pick faces senators
President Trump’s pick to lead the National Institutes of Health (NIH) faced questions from senators Wednesday on his plans ...
The COVID ‘contrarians’ are in power. We still haven’t hashed out whether they were right
Disagreements about what worked and what didn’t against the biggest public health disaster in modern times have yet to be ...
STAT3d
Amgen starts late-stage studies of MariTide
Elsewhere in the obesity space — Amgen has initiated Phase 3 trials of its obesity drug MariTide, one in overweight and obese ...
Alaska Dispatch News1d
Marty Makary, often wrong as pandemic critic, is poised to lead the FDA he railed against
Should Marty Makary take the reins at the FDA, transitioning from gadfly to the head of an agency that regulates a fifth of ...